Monoclonal antibody and viral vector manufacture share similarities, but vector scale up faces unique challenges. Scale up in gene therapy manufacturing currently revolves around viral vector scale up ...
Antiquated infrastructure in the United States is not confined to crumbling roads and bridges. Recent events have shown that connected devices in our cell towers, pipelines, water treatment facilities ...
Scale up in gene therapy manufacturing currently revolves around viral vector scale up. Although some processes are similar to those in monoclonal antibody (mAb) production (e.g., cell culture to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback